Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on Shukra Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Shukra Pharmaceuticals Ltd Share Price Chart
SHUKRAPHARMA at 04 Feb 2026 05:46 PM Pharmaceuticals
38.88 -0.73(-1.84%)
Lowest Today 38.02
Highest Today 40.98
Today's Open 39.60
Prev. Close 39.61
52 Week High 65.26
52 Week Low 11.74
Shukra Pharmaceuticals Ltd Fundamentals
Traded Volume: 2,04,002
Market Cap(Cr): 1,702
Avg Traded Price 39.13
1 Year return 63.29%
Upper Circuit 41
Lower Circuit 38
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) 79.32
EPS TTM NaN
Book value/Share NaN
Dividend Yield 1Y 0.00%
Shukra Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Shukra Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Shukra Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y +63.29%
YTD 0.00%
Shukra Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Shukra Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Shukra Pharmaceuticals Ltd Technical Details
Shukra Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 37
Support 2 36
Support 3 34
Pivot Point : 39
Resistance 1 40
Resistance 2 42
Resistance 3 43
Shukra Pharmaceuticals Ltd Corporate Actions
Shukra Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Shukra Pharmaceuticals Ltd’s capital allocation strategies.
All
Ex-Date 18-Sep-2025 Type D Description 0.01/share@1.00% Record Date 18-Sep-2025 Ratio 1.00
Ex-Date 21-Mar-2025 Type S Description share@1:10.00 Record Date 21-Mar-2025 Ratio 1:10.00
Ex-Date 23-Sep-2024 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00
Ex-Date 19-Apr-2024 Type B Description share@3:1 Record Date 20-Apr-2024 Ratio 3:1
Ex-Date 15-Sep-2023 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00
Ex-Date 02-Feb-2023 Type R Description /share@6:1% Record Date 02-Feb-2023 Ratio 6:1
Ex-Date 22-Sep-2022 Type D Description 0.50/share@5.00% Record Date 22-Sep-2022 Ratio 5.00
Ex-Date 19-Sep-2019 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00
Ex-Date 31-Aug-2018 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00
Ex-Date 01-Sep-2017 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00
Dividends
Announcement Date 18-Sep-2025 Ex Dividend Date 18-Sep-2025 Dividend(%) 1
Announcement Date 23-Sep-2024 Ex Dividend Date 23-Sep-2024 Dividend(%) 10
Announcement Date 15-Sep-2023 Ex Dividend Date 15-Sep-2023 Dividend(%) 5
Announcement Date 22-Sep-2022 Ex Dividend Date 22-Sep-2022 Dividend(%) 5
Announcement Date 19-Sep-2019 Ex Dividend Date 19-Sep-2019 Dividend(%) 5
Announcement Date 31-Aug-2018 Ex Dividend Date 31-Aug-2018 Dividend(%) 5
Announcement Date 01-Sep-2017 Ex Dividend Date 01-Sep-2017 Dividend(%) 5
Bonus
Record Date 20-Apr-2024 Ex-Bonus Date 19-Apr-2024 Ratio 3:1
Splits
Record Date 21-Mar-2025 Split Date 21-Mar-2025 Face Value (Before/After) 10.00/1.00
Others
Ex-Rights Date 02-Feb-2023 Premium(Rs.) 10.00 Ratio 6:1
Shukra Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Shukra Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Shukra Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Stock Name Bliss GVS Pharma Ltd ₹184.28 (+2.08%) M. Cap (Cr) 19.49 1 Yr Return (%) +27.82% P/E (TTM) 17.78 PB Ratio 1.72
Stock Name Amrutanjan Health Care Ltd ₹635.05 (+8.98%) M. Cap (Cr) 18.36 1 Yr Return (%) -4.22% P/E (TTM) 32.26 PB Ratio 5.37
Stock Name Windlas Biotech Ltd ₹854.55 (+1.88%) M. Cap (Cr) 18.01 1 Yr Return (%) -11.43% P/E (TTM) 26.61 PB Ratio 3.35
Stock Name Shukra Pharmaceuticals Ltd ₹38.88 (-1.84%) M. Cap (Cr) 17.02 1 Yr Return (%) +63.29% P/E (TTM) 57.83 PB Ratio 25.63
Stock Name Beta Drugs Ltd ₹1456.90 (+1.22%) M. Cap (Cr) 14.71 1 Yr Return (%) -25.70% P/E (TTM) PB Ratio 6.65
Stock Name NGL Fine Chem Ltd ₹2164.20 (+20.00%) M. Cap (Cr) 13.37 1 Yr Return (%) +36.87% P/E (TTM) 38.09 PB Ratio 4.45
Stock Name Syncom Formulations (India) Ltd ₹14.06 (+5.16%) M. Cap (Cr) 13.22 1 Yr Return (%) -19.98% P/E (TTM) 20.95 PB Ratio 3.49
Shukra Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Shukra Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 7.92
PARTICULARS Investing Activities Mar 2025 -1.26
PARTICULARS Financing Activities Mar 2025 -4.52
PARTICULARS Net Cash Flow Mar 2025 2.14
Shukra Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of Shukra Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 2013-14, the Company got approval from Hon'ble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited with the erstwhile Relish Pharmaceuticals Limited and Re-organization of Share Capital of Relish Pharmaceuticals Limited through the Scheme of Arrangement vide Hon'ble High Court of Gujarat order dated 20 December, 2013.The Company has achieved WHO-GMP certification, successfully securing a partnership with Meril Healthcare for robotic surgery projects in October 2025.
Chairman & Managing Director
Dakshesh Shah
Registered office 3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054
FAX :91-079-66522247/27498515
Background
Incorporation Year 1993
Face Value ₹1.00
Market Lot 1
FAQs on Shukra Pharmaceuticals Ltd
How to buy Shukra Pharmaceuticals Ltd shares on NSE?
To buy Shukra Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Shukra Pharmaceuticals Ltd share price today?
The Shukra Pharmaceuticals Ltd share price on NSE is ₹38.88 today.
What is the market cap of Shukra Pharmaceuticals Ltd on NSE?
The company has a market capitalization of ₹1702.48.
What is the PE & PB ratio of Shukra Pharmaceuticals Ltd?
PE is N/A and PB is N/A.
What is the 52 Week High and Low of Shukra Pharmaceuticals Ltd shares?
Shukra Pharmaceuticals Ltd stock price high: ₹65.26 Shukra Pharmaceuticals Ltd stock price low: ₹11.74.